ConductScience.org, home

Paper8740979

Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.

Höbarth K and 5 others. Urol Res, 1996. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma. Papers, record 8740979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8740979

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.
PubMed
Journal
Urol Res
PubMed
Year
1996
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2019-09-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Höbarth KK
2Hallas AA
3Steiner GG
4Gomahr AA
5Aulitzky WW
6Marberger MM

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BiomarkersMajor topic
Carcinoma, Renal CellMajor topic
ImmunotherapyMajor topic
Interferon-gammaMajor topic
Kidney NeoplasmsMajor topic
Adult
Aged
CD4 Antigens
CD8 Antigens
E-Selectin
Female
Histocompatibility Antigens Class I
Humans
Intercellular Adhesion Molecule-1
Male
Middle Aged
beta 2-Microglobulin

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13289570Role of the major histocompatibility complex class I antigens in tumor growth and metastasis.Annu Rev Immunol1988https://conductscience.org/library/papers/3289570PubMed
23873616Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection.Nature1985https://conductscience.org/library/papers/3873616PubMed
36425403Modulation of class I HLA antigens on HL-60 promyelocytic leukemia cells by serum-free medium: re-induction by gamma-IFN and 1,25-dihydroxyvitamin D3 (calcitriol).J Immunol1984https://conductscience.org/library/papers/6425403PubMed
46206183Activation of human macrophages. Comparison of other cytokines with interferon-gamma.J Exp Med1984https://conductscience.org/library/papers/6206183PubMed
5301122Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.Int J Cancer1977https://conductscience.org/library/papers/301122PubMed
63129362Interferon-gamma for the treatment of metastatic renal cancer: dose-dependent stimulation and downregulation of beta-2 microglobulin and neopterin responses.Immunobiology1987https://conductscience.org/library/papers/3129362PubMed
72408137Expression of activation antigens on T cells in rheumatoid arthritis patients.Scand J Immunol1990https://conductscience.org/library/papers/2408137PubMed
82421465The regulation of expression of major histocompatibility complex products.Transplantation1986https://conductscience.org/library/papers/2421465PubMed
94044058Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell.Int J Cancer1985https://conductscience.org/library/papers/4044058PubMed
101691492Immunophenotypic markers in renal cell carcinoma.Mod Pathol1990https://conductscience.org/library/papers/1691492PubMed
112137658Influence of cyclic interferon gamma on lymphocytes and their subpopulations in patients with renal carcinoma.Urology1990https://conductscience.org/library/papers/2137658PubMed
126981813Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6981813PubMed
132454879Cytokines in the control of beta-2 microglobulin release. II. In vivo studies with recombinant interferons and antigens.Immunobiology1988https://conductscience.org/library/papers/2454879PubMed
142947550Suppressor cell activities in autologous human tumor systems. Suppression of tumor immunity.Arch Surg1986https://conductscience.org/library/papers/2947550PubMed
152219564Immune status and immune therapy of renal cell carcinoma.Urol Int1990https://conductscience.org/library/papers/2219564PubMed
162411792Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.J Immunol1985https://conductscience.org/library/papers/2411792PubMed
172949064Suppressor cell function in solid tumor cancer patients.J Clin Oncol1987https://conductscience.org/library/papers/2949064PubMed
182106352Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia.Blood1990https://conductscience.org/library/papers/2106352PubMed
192970871Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.Blood1988https://conductscience.org/library/papers/2970871PubMed
201967552Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.Cancer Res1990https://conductscience.org/library/papers/1967552PubMed

See all 39 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn Papers
36688998Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab.Cancer Immunol Immunother2023https://conductscience.org/library/papers/36688998

Source PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
SCD579966PubTator's text mininghttps://conductscience.org/library/genes/79966NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8740979

GET https://conductscience.org/api/papers/v1/8740979/references?page=2